Companies

Cadila Pharmaceuticals loses three employees to Covid

Our Burea Ahmedabad | Updated on May 22, 2020 Published on May 22, 2020

Amid the outbreak of pandemic Covid-19, companies are facing a challenge of keeping their employees safe from the infections.

Notably, in a tragic turn of events Ahmedabad-based Rajiv Modi-promoted Cadila Pharmaceuticals Limited recently lost three of its employees among the 26 who had tested positive for Covid-19 at its Dholka manufacturing facility earlier this month. The company had closed its plant operations from May 6. About 1,200-1,600 workers work at its Dholka facility.

“We have lost three of our colleagues to Covid-19. Two of them were working in the packaging department, third person was also there. One of them was 59-years old and had comorbid conditions with diabetes. It is a tragic thing for us, but we are ensuring they get all benefits that they deserve as an employee and also we will see how we can extend all possible help to their families,” said a Cadila Pharmaceuticals spokesperson.

Of the other infected employees, about 90 per cent are home quarantined. Company’s Dholka plant is currently under shutdown. “An unfortunate thing had happened. But we expect the operations to resume soon after the plant shutdown,” the spokesperson added.

On the other hand, one more leading pharma company in the State has seen three of its employees testing positive for Covid-19. However, the employees are said to be working in the laboratory, hence there is no impact on the company’s plant operations. Sources revealed that the employees contracted the infection from their residential neighbourhood, and not from the workplace.

“This is a pandemic situation. We don’t know who around us is carrying the virus. Anyone who catches the infection, obviously would be working somewhere be it pharma sector or any other. Important aspect is that our pharmaceutical industry is fully geared up for employee safety and takes strict precautionary measures within the plant and outside,” said Kamlesh Patel, former chairman, Gujarat State Council of Indian Drug Manufacturers’ Association.

Published on May 22, 2020

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Sincerely,

Support Quality Journalism
Kia Motors launches campaign for sanitation, hygiene checks